FDA — authorised 23 March 2012
- Application: NDA202813
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: QNASL
- Indication: AEROSOL, METERED — NASAL
- Status: approved
🇺🇸 QNASL in United States
FDA authorised QNASL on 23 March 2012
Marketing authorisations
FDA
- Status: approved
QNASL in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is QNASL approved in United States?
Yes. FDA authorised it on 23 March 2012; FDA has authorised it.
Who is the marketing authorisation holder for QNASL in United States?
TEVA BRANDED PHARM holds the US marketing authorisation.